Renaissance Technologies LLC Sells 612,900 Shares of Thermo Fisher Scientific Inc (TMO)

Renaissance Technologies LLC trimmed its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 44.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 760,144 shares of the medical research company’s stock after selling 612,900 shares during the period. Renaissance Technologies LLC owned about 0.19% of Thermo Fisher Scientific worth $132,622,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in TMO. BlackRock Inc. lifted its holdings in Thermo Fisher Scientific by 2,692.1% in the 1st quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock valued at $3,531,095,000 after purchasing an additional 22,165,530 shares in the last quarter. Veritas Asset Management LLP lifted its holdings in Thermo Fisher Scientific by 112.4% in the 2nd quarter. Veritas Asset Management LLP now owns 2,430,759 shares of the medical research company’s stock valued at $424,095,000 after purchasing an additional 1,286,259 shares in the last quarter. Harbour Capital Advisors LLC lifted its holdings in Thermo Fisher Scientific by 18,197.5% in the 2nd quarter. Harbour Capital Advisors LLC now owns 1,201,051 shares of the medical research company’s stock valued at $6,884,000 after purchasing an additional 1,194,487 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Thermo Fisher Scientific by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 25,971,301 shares of the medical research company’s stock valued at $3,989,193,000 after purchasing an additional 695,079 shares in the last quarter. Finally, Investec Asset Management LTD lifted its holdings in Thermo Fisher Scientific by 37.5% in the 2nd quarter. Investec Asset Management LTD now owns 1,697,411 shares of the medical research company’s stock valued at $296,147,000 after purchasing an additional 463,245 shares in the last quarter. Institutional investors own 83.61% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.com-unik.info/2017/10/30/renaissance-technologies-llc-sells-612900-shares-of-thermo-fisher-scientific-inc-tmo.html.

In other news, Director C Martin Harris sold 360 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total transaction of $65,149.20. Following the completion of the sale, the director now directly owns 5,312 shares in the company, valued at approximately $961,312.64. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Daniel P. Shine sold 2,026 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $366,645.22. Following the sale, the insider now owns 20,682 shares of the company’s stock, valued at $3,742,821.54. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 52,738 shares of company stock valued at $9,302,112. 0.49% of the stock is owned by corporate insiders.

A number of research analysts have issued reports on the stock. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Monday, September 18th. Wells Fargo & Company reaffirmed an “outperform” rating and set a $200.00 price objective (up previously from $195.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 13th. Bank of America Corporation reaffirmed a “buy” rating and set a $210.00 price objective (up previously from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. Cleveland Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research note on Thursday, July 20th. Finally, BidaskClub downgraded shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. One investment analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $205.50.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at 192.42 on Monday. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $201.20. The company’s 50-day moving average is $191.73 and its 200-day moving average is $178.12. The firm has a market cap of $75.07 billion, a P/E ratio of 33.52 and a beta of 1.05.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.24 by $0.07. The business had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The firm’s revenue was up 13.9% on a year-over-year basis. During the same period in the previous year, the company earned $2.03 EPS. Equities research analysts forecast that Thermo Fisher Scientific Inc will post $9.36 earnings per share for the current fiscal year.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit